First human trial of potential coronavirus antibody treatment begins: Top updates on Covid-19 vacci
- 4 years ago
First human trial of potential coronavirus antibody treatment begins: Top updates on Covid-19 vaccine
India has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
As the number of coronavirus cases race beyond the 6 million-mark globally, scientists and experts are speeding up the effort to arrive at the potential vaccine for Covid-19.
In what can be termed as nothing short of a stepping stone in India’s fight against Covid-19, New Delhi has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
• Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in Covid-19 patients in formal clinical trials and is at the forefront of the battle against Covid-19, which has no approved treatment or vaccine.
The drug was granted emergency use authorization by the US Food and Drug Administration last month a
India has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
As the number of coronavirus cases race beyond the 6 million-mark globally, scientists and experts are speeding up the effort to arrive at the potential vaccine for Covid-19.
In what can be termed as nothing short of a stepping stone in India’s fight against Covid-19, New Delhi has approved Gilead Sciences Inc’s antiviral drug remdesivir for emergency use for five doses in treating Covid-19 patients.
• Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in Covid-19 patients in formal clinical trials and is at the forefront of the battle against Covid-19, which has no approved treatment or vaccine.
The drug was granted emergency use authorization by the US Food and Drug Administration last month a